Form 4: Molina Healthcare Executive Reports Stock Transactions Following PSU Vesting and Restricted Stock Grant

Chief Accounting Officer Maurice Hebert reports acquisition and disposal of Molina Healthcare stock related to performance stock unit vesting and a restricted stock grant.

Summary

• On March 1, 2024, Maurice Hebert, Chief Accounting Officer of Molina Healthcare, Inc., reported transactions involving the company's common stock.
• These transactions include the acquisition of 1,530 shares at $387.21 related to the vesting of performance stock units (PSUs) granted on March 1, 2021.
• The PSUs vested at 170% achievement level based on the company's averaged achievement of adjusted net income per share in the three fiscal years of 2021, 2022, and 2023.
• Hebert also disposed of 450 shares and 516 shares at $387.21 to cover withholding taxes related to the vesting of the PSUs and other shares.
• Additionally, Hebert acquired 516 shares at $387.12 and 258 shares at $387.21 as part of a restricted stock grant under the company's 2019 Equity Incentive Plan.
• Following these transactions, Hebert beneficially owns 9,866 shares of Molina Healthcare common stock.
• 774 of the newly granted shares will vest in one-third increments on March 1, 2025, March 1, 2026, and March 1, 2027.
• 643 shares shall vest on March 1, 2025; and 243 shares shall vest on March 1, 2026.
• The remaining shares are vested.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document primarily reports routine stock transactions related to executive compensation. The vesting of PSUs at 170% is a positive indicator, but the overall impact is balanced by the tax-related disposals.

Positives

• The vesting of performance stock units at 170% suggests strong performance relative to the targets set when the units were granted.
• The grant of restricted stock indicates a continued investment in the company's future by its executives.

Future Outlook

The document outlines the vesting schedule for the newly granted restricted stock, with portions vesting on March 1 of 2025, 2026 and 2027.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are closely monitored by investors for insights into management's confidence in the company's prospects.

Comparison to Industry Standards

• Stock-based compensation, including PSUs and restricted stock, is a common practice among publicly traded healthcare companies like UnitedHealth Group, Anthem (now Elevance Health), and Cigna.
• The vesting schedules and performance metrics associated with these grants often vary based on company-specific goals and industry benchmarks.
• For example, some companies may use revenue growth, earnings per share, or total shareholder return as key performance indicators for PSU vesting.

Stakeholder Impact

• The vesting of performance stock units and grant of restricted stock can incentivize management to focus on long-term value creation, benefiting shareholders.
• Tax-related disposals have a negligible impact on stakeholders.

Key Dates